6 Dimensions Capital

6 Dimensions Capital

6 Dimensions Capital is a healthcare and life sciences focused investment firm.

6 Dimensions Capital is an investment firm focused on healthcare and life sciences companies in China, Europe, Israel, and the United States. It has offices in Shanghai, Hong Kong, Boston, and San Francisco.

Founded in 2017, 6 Dimensions Capital is led by Dr. Ge Li, the founder, Chairman and CEO of WuXi AppTec, and a Founding Partner of WuXi Healthcare Ventures, who is the Chairman of the Board, Dr. Leon Chen, the Founder and Managing Partner of Frontline BioVentures, who is the CEO. The investment team will consist of 26 investment professionals, including 9 Partners and 7 Venture Partners.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
Grail

Grail is a biotechnology company headquartered in Menlo Park, California that was founded as a spinoff of Illumina Inc and initially headed by Jeffrey Huber in 2016, focused on making a medical device that can detect early stage cancer.

A biotechnology company developing drugs and treatments to diminish negative health effects associated with aging.

TCR2 Therapeutics is a biotechnology company developing T cell hematologic cancer immunotherapies.

Kymera Therapeutics is a Cambridge, Massachusetts-based biotechnology company specialized in the field of targeted protein degradation.

IDEAYA Biosciences is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality

Neuspera Medical is a San Jose, California-based medical device company.

Centrexion Therapeutics is a Boston-based company.

Brii Biosciences is a Durham, North Carolina-based company.

Viela Bio is a Gaithersburg, Maryland-based company.

13 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.